Hepatitis Monthly

Official Twitter account of Hepatitis Monthly Journal
Indexed in: WOS (SCIE, IF=1.214) and Scopus (CiteScore=1.1)

[Hepatitis Monthly @Hepatmon]

Serum Fibroblast Growth Factor 19 as a Biomarker in Hepatitis B Virus-Related Liver Disease 🇨🇳

#HBV #cirrhosis #fibrosis #HCC

📃Read at: https://t.co/VI9PWr7kLn

[Hepatitis Monthly @Hepatmon]

The Efficacy of Antiviral Treatment for Chronic Hepatitis B Patients with Normal ALT Levels: A Systematic Review and Meta-analysis 🇨🇳

#HBV #ALT #liver #hepatitis

📃Read at: https://t.co/Y6rivBzgFK

[Hepatitis Monthly @Hepatmon]

Seroprevalence of Hepatitis B Virus and Hepatitis C Virus Infections Among People with Severe Mental Illness in Tehran, Iran 🇮🇷

by: @profalavian @fotouhi_akbar @HeidarSharafi

#HCV #HBV #PTSD #Schizophrenia #ADHD #autism #prevalence

📃Read at: https://t.co/jjBCtt0qfV

[Hepatitis Monthly @Hepatmon]

Post-Intervention Plasma IL-10 Level Predicts Early Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization 🇨🇳

#HCC

📃Read at: https://t.co/8Zv3kY5qST

[Hepatitis Monthly @Hepatmon]

Inhibitory Effects of Gabapentin on the Proliferation and Cell Motility of Hepatocellular Carcinoma Cells 🇨🇳🇬🇧

#HCC

📃Read at: https://t.co/1gT5iTP7O2

[Hepatitis Monthly @Hepatmon]

Proportion of People Who Are Positive for HBsAg and Anti-HCV Antibody Among Participants in a Community Screening Campaign in Malaysia 🇲🇾

#HCV #HBV

📃Read at: https://t.co/eqzwJpLpXA

[Hepatitis Monthly @Hepatmon]

Elevated Pancreatic Enzymes Associated with Acute Liver Injury Were Mediated by Tumor Necrosis Factor-Alpha Signaling 🇯🇵

#Liver

📃Read at: https://t.co/KOr2YIU97e

[Hepatitis Monthly @Hepatmon]

Biochemical and Bioinformatic Characterization of Patients with a Sodium Taurocholate Cotransporting Polypeptide Mutation 🇨🇳

📃Read at: https://t.co/GCh3eXzkhw

[Hepatitis Monthly @Hepatmon]

Prevalence of Hepatic Space-Occupying Lesions Based on Sonographic Findings in Patients Referred to Guilan Cohort Center, Iran 🇮🇷

📃Read at: https://t.co/rtaMTGHx6Z

[Hepatitis Monthly @Hepatmon]

Epidemiology of Hepatitis C Virus Infection Among High-risk Populations in Northeastern Iran 🇮🇷

#HCV

📃Read at: https://t.co/gORaQhkYJP

[Hepatitis Monthly @Hepatmon]

Hepatitis E Virus; An Underestimated Threat for the Viral Hepatitis Elimination Program 🇧🇪🇮🇷

by @purkarim1

#HEV

📃Read at: https://t.co/1Cme5Jqgae

[Hepatitis Monthly @Hepatmon]

Comparison of Postoperative Prognosis Among HBV-Related, HCV-Related, and non-HBV non-HCV Hepatocellular Carcinomas: A Systematic Review and Meta-analysis 🇨🇳

#HBV #HCV #HCC

📃Read at: https://t.co/H95TUTcq5H

[Hepatitis Monthly @Hepatmon]

Comparing RT-qPCR and Hepatitis C Virus Antigen Detection Assay for Detecting Active Infection in Blood Donors in Fars Province, Iran 🇮🇷

#HCV

📃Read at: https://t.co/NgReNu25W2

[Hepatitis Monthly @Hepatmon]

Identification of Shared Gene Signatures in Different Stages of Nonalcoholic Fatty Liver Disease Using Integrated Microarray Datasets 🇮🇷

#NAFLD

📃Read at: https://t.co/qeobdo9PBF

[Hepatitis Monthly @Hepatmon]

Can Gamma-glutamyl Transferase Predict Unhealthy Metabolic Phenotypes Among Healthcare Workers in Azar Cohort Study? 🇮🇷

📃Read at: https://t.co/Qf3VDoo6Fq

[Hepatitis Monthly @Hepatmon]

TGFβ1-Pretreated Exosomes of Wharton Jelly Mesenchymal Stem Cell as a Therapeutic Strategy for Improving Liver Fibrosis 🇮🇷

📃Read at: https://t.co/JmF4tSIs6X

[Saeid Ghavami @CellAutophagy]

Excited to share our recent publication of "Therapeutic potential of targeting regulatory mechanisms of hepatic st... https://t.co/iTuOSHBfkK
@Hepatmon @ElsevierConnect @BBAjournals @AutophagyPapers @UM_RadyFHS @um_HACS_GSA

[Siavash Miri @DrMiri]

"Do not review for your colleagues"

It is a very simple principle of #conflict_of_interest in #peer_review.

But #why do we like to forget this important principle during the review?

[Hepatitis Monthly @Hepatmon]

Acute Hepatitis of Unknown Origin in Children; Lessons Learned from the COVID-19 Pandemic 🇧🇪🇮🇷

#COVID19

by: @purkarim1

📃Read at: https://t.co/2114XZFQ56

[Hepatitis Monthly @Hepatmon]

Relationship Between Cardiovascular Disease Risk Factors and Quality of Life in Patients with Metabolic-Associated Fatty Liver Disease 🇮🇷

#MAFLD

📃Read at: https://t.co/3v3fY5tm6u